Advertisement

Topics

Latest "Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)" News Stories

02:07 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)" found in our extensive news archives from over 250 global news sources.

More Information about Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) for you to read. Along with our medical data and news we also list Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Clinical Trials, which are updated daily. BioPortfolio also has a large database of Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Companies for you to search.

Showing "Organized Program Initiate Lifesaving Treatment Hospitalized Patients With" News Articles 1–25 of 35,000+

Wednesday 20th March 2019

AmCham EU CEO emphasizes opportunities US business bring to Europe

Interview with Susan Danger, CEO of the American Chamber of Commerce to the EU (AmChamEU).1. The theme of your transatlantic conference this year was ‘Atlantic drift? The EU, the US and the WTO in a new world.’ What was your main takeaway from the conference? Are we drifting?The EU and the US are historic partners and allies and our relationship is here to stay. Having said that, there are a f...


p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

STAT Plus: A new and pricey rare-disease drug that angered many patients — and prompted @SenBernie Sanders to protest its cost — is showing signs of becoming a hit on Wall Street. https://buff.ly/2CuC565 

STAT Plus: A new and pricey rare-disease drug that angered many patients — and prompted @SenBernie Sanders to protest its cost — is showing signs of becoming a hit on Wall Street. https://buff.ly/2CuC565 


CORRECTING and REPLACING Trust, Value, Credibility – A Guided Approach to Thought Leadership from PAN Communications

New eBook connects programs to increased share of voice and brand awareness Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TRUST, VALUE, CREDIBILITY – A GUIDED APPROACH TO THOUGHT LEADERSHIP FROM PAN COMMUNICATIONS New eBook connects prog...

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 

[Seminar] Tuberculosis

Tuberculosis remains the leading cause of death from an infectious disease among adults worldwide, with more than 10 million people becoming newly sick from tuberculosis each year. Advances in diagnosis, including the use of rapid molecular testing and whole-genome sequencing in both sputum and non-sputum samples, could change this situation. Although little has changed in the treatment of drug-su...

[Perspectives] Nandita Venkatesan: a voice of hope for tuberculosis survivors

“If you don't listen to someone's first-hand suffering you're not going to know how it feels to suffer all this pain”, says Nandita Venkatesan. She is adamant “it's high time” governments listen and take into account the views of people affected by tuberculosis. As a tuberculosis survivor, Venkatesan, a journalist and a patients' rights advocate, speaks with passion about the pain, the sti...

[Perspectives] Picturing health: it's time to act on tuberculosis

Tuberculosis is the world's most deadly infectious disease. Every year, an estimated 1·6 million people die from tuberculosis and 10 million are infected with the disease, with about 3·6 million people undiagnosed or detected but not reported. Case finding and contact tracing are huge challenges. Many people worldwide do not have access to testing or treatment, especially for multidrug-resistant...

3SBio Unveils 2018 Annual Results: Revenue Soars by 22.7%, Normalized Net Profit Soars by 29.0%, R&D Expenses Jumps Over 40%

HONG KONG, March 21, 2019 /PRNewswire/ -- Chinese leading biotechnology company 3SBio (01530.HK) today released its 2018 annual results, showing that the Company has been posting dramatic business growth, and has been gearing up R&D layout and investment in innovative drugs. Financial highlights showed that the Company's revenue increased by approximately 22.7% to approximately RMB 4,583.9 m...

Aeroflow Healthcare to Host April Diaper Drive to Benefit Diaper Bank of North Carolina

Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that its Urology division will host a diaper drive from April 22-26, during national Every Kid Healthy™ Week, to benefit Diaper Bank of North Carolina. ASHEVILLE, N.C. (PRWEB) March 20, 2019 Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that its Urology division will host a diaper drive from ...

Bio-Trac Adds World-Renown Stem Cell Expert Dr. Mahendra S. Rao to Its Team as Co-Director

One of the most influential minds in stem cell research, Dr. Rao will enhance Bio-Trac’s already strong hands-on research training workshop offerings as new Co-Director. GERMANTOWN, Md. (PRWEB) March 20, 2019 Bio-Trac®, a leading provider of graduate and postgraduate laboratory training workshops, announced today that regenerative medicine and stem cell research pioneer Dr. Mahendra S. Rao...

City of Hope Awarded $7.5 Million to Develop Better Treatment for a Rare, Incurable Cancer

The institute’s multidisciplinary cutaneous lymphoma program has given hope to countless patients who suffer from the disfiguring disease. City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma (CTCL). The National Cancer Institute (NCI) awarded two gr...

Agilent Technologies Announces Cash Dividend of 16.4 Cents per Share

Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 16.4 cents per share of common stock will be paid on April 24, 2019, to all shareholders of record as of the close of business on April 2, 2019. The timing and amounts of future dividends are subject to determination and approval by Agi...

Anthem, Stanford found AI for Health Affiliation program

"You have to grieve a part of you that you can no longer use. And then you have to move on.” @damiangarde tells an amazing story about a rare debilitating disease for which there may actually soon be help. https://www.statnews.com/2019/03/20/fibrodyspla

"You have to grieve a part of you that you can no longer use. And then you have to move on.” @damiangarde tells an amazing story about a rare debilitating disease for which there may actually soon be help. https://www.statnews.com/2019/03/20/fibrodysplasia-ossificans-progressiva-fop-treatment/?utm_source=STAT+Newsletters&utm_campaign=9625ce06f6-Readout_COPY_03&utm_medium=email&...

Athenex Sues FDA To Get Vasopressin On List Of Drugs That Can Be Compounded

Company argues there is a clinical need for its ready-to-use, preservative-free compounded formulation of vasopressin but agency says Vasostrict is...   

Your NEJM Group Today: Navigating Social Distance / Reducing Readmissions in Medicaid Patients / Primary Care & Pediatrics Opportunities

Check out the latest from NEJM Group: NEJM Audio Interview: Navigating Social Distance: Dr. Laszlo Madaras discusses caring for people who diverge from the typical...

Getting Post-Acute Care At Home Is Cheaper, But Not Better Than A Skilled Nursing Facility

A new study finds that post-acute care at home costs Medicare less, but isn't better for patients. We need to learn why.

Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand

Alexion Pharmaceuticals today announced a pair of collaborations totaling potentially more than $1.3 billion—one partnership aimed to co-developing an autoimmune disease treatment, and another aimed at expanding Alexion’s pipeline into peptide therapies. Alexion agreed to co-develop Affibody’s Phase I bivalent antibody-mimetic ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune disea...

New analysis shows 820,000 prescriptions would be in jeopardy if ICER’s value framework is used in Medicaid

A new analysis from Xcenda found that if Medicaid were to use one-size-fits-all value assessments like the Institute for Clinical and Economic Review’s (ICER) framework as the basis for accessing a medicine, an estimated 42 to 99 percent of prescriptions to treat serious, complex conditions like cancer and

Brain Surgery for Metastasis Tied to Distinctive Tumor Spread

In the absence of whole-brain radiation, neurosurgical resection in patients with brain metastases may boost pachymeningeal seeding, a new study hints. Reuters Health Information

Despite Progress in Follicular Lymphoma and MCL, Critical Questions Remain

Izidore S. Lossos, MD, discusses the current pillars of care and barriers in the treatment of patients with early-stage and advanced follicular lymphoma, as well as mantle cell lymphoma.

Jazz Pharma's sleep disorder treatment gets FDA nod

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.

Antiepileptic Drugs Not Tied to Dementia Risk

WEDNESDAY, March 20, 2019 -- Antiepileptic drug (AED) use is not significantly associated with dementia risk in patients in Germany, according to a study published online March 12 in the Journal of Alzheimer's Disease. Louis Jacob, Ph.D., from the...

Why Is It So Hard to Match Patients with Their Medical Records?

(Undark) – These aren’t strange outliers; they are the everyday world of health care. Patient-matching — accurately matching patients to their medical records — bedevils every hospital, doctor’s office, laboratory, and other health care facility, risking patient safety and wasting … Read More


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks